Fluidiconic Biotechnology aims to redefine preclinical drug screening through tumor microenvironment simulation.

Our core product series, MedSelect™ platforms, create microfluidic-based 3D co-culture system that replicates key features of the ex vivo tumor microenvironment. It enables precise evaluation of drug response, immune cell behavior, and tissue-level gradients in real time.

Applications include preclinical optimization, reduction of animal testing, and patient-specific drug response profiling. We welcome collaborations with pharma, CROs, and research teams to accelerate ethical, efficient oncology innovation.

Fluidiconic Biotechnology

Org chart

Teams

Offices

Fluidiconic Biotechnology

Org chart

Teams

Offices

Related companies